当前位置: 首页 > 详情页

Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Cerebral Vascular Diseases Research Institute (China-America Institute of Neuroscience), Xuanwu Hospital, and Department of Neurology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China [2]Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston [3]Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, MI [4]Department of Biochemistry & Molecular Biology,Complex Carbohydrate Research Center, University of Georgia, Athens.
出处:
ISSN:

摘要:
Objective: This study aims to evaluate protective effects of brief repetitive bilateral arm ischemic preconditioning (BAIPC) on stroke recurrence in patients with symptomatic atherosclerotic intracranial arterial stenosis (IAS). Methods: A total of 68 consecutive cases with symptomatic IAS, diagnosed by imaging, were enrolled in this prospective and randomized study. All patients received standard medical management. Patients in the BAIPC group (n = 38) underwent 5 brief cycles consisting of bilateral upper limb ischemia followed by reperfusion. The BAIPC procedure was performed twice daily over 300 consecutive days. Incidence of recurrent stroke and cerebral perfusion status in BAIPC-treated patients were compared with the untreated control group (n = 30). Results: In the control group, incidence of recurrent stroke at 90 and 300 days were 23.3% and 26.7%, respectively. In the BAIPC group, incidence of recurrent stroke was reduced to 5% and 7.9% at 90 and 300 days (p < 0.01), respectively. The average time to recovery (modified Rankin Scale score 0-1) was also shortened by BAIPC. Cerebral perfusion status, measured by SPECT and transcranial Doppler sonography, improved remarkably in BAIPC-treated brain than in control (p < 0.01). Conclusion: This study provides a proof-of-concept that BAIPC may be an effective way to improve cerebral perfusion and reduce recurrent strokes in patients with IAS. Further investigation of this therapeutic approach is warranted as some patients were excluded after randomization. Neurology (R) 2012; 79: 1853-1861

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 1 区 医学
小类 | 1 区 临床神经病学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 临床神经病学
JCR分区:
出版当年[2010]版:
Q1 CLINICAL NEUROLOGY
最新[2023]版:
Q1 CLINICAL NEUROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者机构: [1]Cerebral Vascular Diseases Research Institute (China-America Institute of Neuroscience), Xuanwu Hospital, and Department of Neurology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China [2]Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
通讯作者:
通讯机构: [1]Cerebral Vascular Diseases Research Institute (China-America Institute of Neuroscience), Xuanwu Hospital, and Department of Neurology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院